Suchergebnisse - "Tiğlioğlu, Pinar"

PubPharm (11)

1

A challenging issue in COVID-19 infection : The relationship between PA1-1 and TAFI levels in patients with coagulation disorder: A retrospective and observational study

enthalten in: Medicine | 2024

von Altin, N. | Tiğlioğlu, P. | Ulusoy, T. | +4

2

Change in Hepatitis B Surface Antibody Titers After Chemotherapy in Patients With Hematological Malignancies

enthalten in: Cureus | 2024

von Unver Ulusoy, T. | Tıglıoglu, P. | Demirköse, H. | +2

3

Leukocytoclastic vasculitis due to ruxolitinib treatment : A rare adverse effect

enthalten in: Journal of clinical pharmacy and therapeutics | 2022

von Tığlıoğlu, M. | Tığlıoğlu, P. | Yıldız, A. | +5

4

Vitreous hemorrhage : A rare ophthalmic adverse effect due to imatinib treatment

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2022

von Yılmaz, F. | Albayrak, M. | Tığlıoğlu, P. | +5

5

Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experience

enthalten in: Journal of hematopathology | 2022

von Tığlıoğlu, P. | Albayrak, M. | Yıldız, A. | +7

6

Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experience

enthalten in: Journal of hematopathology | 2022

von Tığlıoğlu, P. | Albayrak, M. | Yıldız, A. | +7

7

Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experience

enthalten in: Journal of hematopathology | 2022

von Tığlıoğlu, P. | Albayrak, M. | Yıldız, A. | +7

8

The outcome of COVID-19 in patients with hematological malignancy

enthalten in: Memo | 2022

von Tığlıoğlu, P. | Albayrak, M. | Tığlıoğlu, M. | +4

9

Leukocytoclastic vasculitis due to ruxolitinib treatment : A rare adverse effect

enthalten in: Journal of clinical pharmacy and therapeutics | 2022

von Tığlıoğlu, M. | Tığlıoğlu, P. | Yıldız, A. | +5

10

The outcome of COVID-19 in patients with hematological malignancy

enthalten in: Magazine of European Medical Oncology | 2021

von Tığlıoğlu, P. | Albayrak, M. | Tığlıoğlu, M. | +4